Docetaxel-Induced Onycholysis: The Role of Subungual Hemorrhage and Suppuration
Open Access
- 1 January 2007
- journal article
- case report
- Published by Yonsei University College of Medicine in Yonsei Medical Journal
- Vol. 48 (1) , 124-126
Abstract
Roh MR, et al. Yonsei Med J. 2007 Feb;48(1):124-126. http://dx.doi.org/10.3349/ymj.2007.48.1.124Keywords
This publication has 14 references indexed in Scilit:
- Severe nail changes due to Docetaxel treatment.2004
- Onycholysis and subungual haemorrhages secondary to systemic chemotherapy (paclitaxel)Journal of the European Academy of Dermatology and Venereology, 2003
- Taxane-induced nail changes: incidence, clinical presentationand outcomeAnnals of Oncology, 2003
- Docetaxel‐induced nail dystrophyAustralasian Journal of Dermatology, 2002
- Nail changes due to docetaxelBritish Journal of Dermatology, 2002
- Nail changes secondary to docetaxelThe Lancet, 2001
- Subungual abscess: a new ungual side-effect related to docetaxel therapyBritish Journal of Dermatology, 2000
- Nail Changes Secondary to Docetaxel (Taxotere)Dermatology, 1999
- Onycholysis Associated with Weekly Administration of PaclitaxelAnnals of Pharmacotherapy, 1999
- Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: a phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of Cancer.Journal of Clinical Oncology, 1995